178) with health literacy among heart failure patients. |
179) are to manage a rise in critically unwell patients. |
180) moking prevalence among COVID-19 infected patients. |
181) kers evaluated were increased in deceased patients. |
182) ortunistic infection in immunocompromised patients. |
183) discussion of anatomy topics, and virtual patients. |
184) armacy management system to flag eligible patients. |
185) ical therapy management in critically ill patients. |
186) o favors anticoagulation in most of these patients. |
187) (ED) is a difficult place for psychiatric patients. |
188) monitoring, and risk-stratifying COVID-19 patients. |
189) was evaluated on a cohort of 65 HN cancer patients. |
190) nt cancer-related palliative care to LGBT patients. |
191) ages with data from both groups of cancer patients. |
192) fluencing ED nurses' care for psychiatric patients. |
193) ase, which were more frequent in European patients. |
194) no prognostic markers to identify at-risk patients. |
195) hospitals from the perspectives of older patients. |
196) ntima-media thickness, except in diabetic patients. |
197) toperative management of single ventricle patients. |
198) ompanied by restricted water diffusion in patients. |
199) hat target improving vaccine uptake in RA patients. |
200) 3 primary studies involving 2880 COVID-19 patients. |
201) n (IFN)-associated immune pathways in SLE patients. |
202) th poor overall survival outcomes in TNBC patients. |
203) a first line option for T2DM drug-naïve patients. |
204) ate multi-organ segmentation in HN cancer patients. |
205) of alcohol-associated liver disease (ALD) patients. |
206) n contouring in head-and-neck (HN) cancer patients. |
207) alyzed cases and case series reporting 43 patients. |
208) cific sequelae in 7,032 CoV2 positive (+) patients. |
209) ll clonality impacting the outcome of RCC patients. |
210) eyond normal range more often in deceased patients. |
|